tiprankstipranks
Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments
PremiumRatingsBuy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments
1M ago
Relay Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
Relay Therapeutics Reports 2024 Financial Results and Progress
1M ago
Relay Therapeutics reports Q4 EPS (45c), consensus (55c)
Premium
The Fly
Relay Therapeutics reports Q4 EPS (45c), consensus (55c)
1M ago
Relay Therapeutics Reports Promising Data on RLY-2608
PremiumCompany AnnouncementsRelay Therapeutics Reports Promising Data on RLY-2608
4M ago
Relay Therapeutics reports updated interim clinical data for RLY-2608
Premium
The Fly
Relay Therapeutics reports updated interim clinical data for RLY-2608
4M ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
4M ago
Relay Therapeutics Reports Q3 2024 Results and Advances
PremiumCompany AnnouncementsRelay Therapeutics Reports Q3 2024 Results and Advances
5M ago
Relay Therapeutics reports Q3 EPS (63c), consensus (77c)
Premium
The Fly
Relay Therapeutics reports Q3 EPS (63c), consensus (77c)
5M ago
Relay Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
Relay Therapeutics participates in a conference call with JPMorgan
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100